The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Entero Therapeutics Inc shares valued at $465 were sold by Romano Sarah on Jan 06 ’25. At $0.64 per share, Romano Sarah sold 727 shares. The insider’s holdings dropped to 17,287 shares worth approximately $10717.94 following the completion of this transaction.
Also, Romano Sarah sold 476 shares, netting a total of over 212 in proceeds. Following the sale of shares at $0.45 each, the insider now holds 18,014 shares.
Before that, Romano Sarah had sold 621 shares from its account. In a trade valued at $664, the Chief Financial Officer traded Entero Therapeutics Inc shares for $1.07 each. Upon closing the transaction, the insider’s holdings decreased to 621 shares, worth approximately $11463.8.
Analyzing ENTO Stock Performance
During the last five days, there has been a drop of approximately -0.32%. Over the course of the year, Entero Therapeutics Inc shares have dropped approximately -0.32%. Shares of the company reached a 52-week high of $0.7000 on 01/07/25 and a 52-week low of $0.6010 on 01/08/25. A 50-day SMA is recorded $0.5888, while a 200-day SMA reached $1.3337. Nevertheless, trading volume fell to 60400.0 shares from 27700.0 shares the previous day.
Support And Resistance Levels for Entero Therapeutics Inc (ENTO)
According to the 24-hour chart, there is a support level at 0.5873, which, if violated, would cause prices to drop to 0.5547. In the upper region, resistance lies at 0.6663. The next price resistance is at 0.7127. RSI (Relative Strength Index) is 51.27 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0264, which suggests the price will decrease in the coming days. Percent R is at 53.66%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
